Structure

Physi-Chem Properties

Molecular Weight:  660.37
Volume:  713.411
LogP:  8.136
LogD:  2.591
LogS:  -3.192
# Rotatable Bonds:  14
TPSA:  135.04
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.116
Synthetic Accessibility Score:  5.151
Fsp3:  0.525
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.865
MDCK Permeability:  2.119248529197648e-05
Pgp-inhibitor:  0.784
Pgp-substrate:  0.917
Human Intestinal Absorption (HIA):  0.211
20% Bioavailability (F20%):  0.78
30% Bioavailability (F30%):  0.003

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.025
Plasma Protein Binding (PPB):  97.97966766357422%
Volume Distribution (VD):  1.563
Pgp-substrate:  1.119447112083435%

ADMET: Metabolism

CYP1A2-inhibitor:  0.039
CYP1A2-substrate:  0.548
CYP2C19-inhibitor:  0.481
CYP2C19-substrate:  0.662
CYP2C9-inhibitor:  0.807
CYP2C9-substrate:  0.979
CYP2D6-inhibitor:  0.818
CYP2D6-substrate:  0.043
CYP3A4-inhibitor:  0.852
CYP3A4-substrate:  0.891

ADMET: Excretion

Clearance (CL):  13.773
Half-life (T1/2):  0.019

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.594
Drug-inuced Liver Injury (DILI):  0.927
AMES Toxicity:  0.003
Rat Oral Acute Toxicity:  0.996
Maximum Recommended Daily Dose:  0.423
Skin Sensitization:  0.06
Carcinogencity:  0.258
Eye Corrosion:  0.003
Eye Irritation:  0.119
Respiratory Toxicity:  0.858

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC326193

Natural Product ID:  NPC326193
Common Name*:   Yungensin C
IUPAC Name:   n.a.
Synonyms:   Yungensin C
Standard InCHIKey:  UKQRDKMWMFEWPI-KOEQRZSOSA-N
Standard InCHI:  InChI=1S/C40H52O8/c1-10-13-30(42)32-34(44)28(33(43)27-18-20-39(8,48-36(27)32)19-12-15-24(4)5)22-29-35(45)31(26(7)41)38(47)40(9,37(29)46)21-17-25(6)16-11-14-23(2)3/h14-15,17-18,20,43-44,46-47H,10-13,16,19,21-22H2,1-9H3/b25-17+
SMILES:  CCCC(=O)c1c(O)c(CC2=C(O)C(C(=C(C2=O)C(=O)C)O)(C)C/C=C(/CCC=C(C)C)C)c(c2c1OC(C)(CCC=C(C)C)C=C2)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1631975
PubChem CID:   NA
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000350] Butyrophenones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17538 Elaphoglossum yungense Species Dryopteridaceae Eukaryota rhizomes and roots Yacuchina, Tucumn, Argentina 2008-DEC PMID[21043474]
NPO17538 Elaphoglossum yungense Species Dryopteridaceae Eukaryota n.a. rhizome n.a. PMID[21043474]
NPO17538 Elaphoglossum yungense Species Dryopteridaceae Eukaryota n.a. root n.a. PMID[21043474]
NPO17538 Elaphoglossum yungense Species Dryopteridaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 50.0 ug.mL-1 PMID[484926]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 50.0 ug.mL-1 PMID[484926]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus GI = 92.0 % PMID[484926]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa GI = 87.0 % PMID[484926]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 100.0 ug ml-1 PMID[484926]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MBC = 50.0 ug ml-1 PMID[484926]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC326193 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC321148
1.0 High Similarity NPC323884
1.0 High Similarity NPC321629
0.9926 High Similarity NPC316560
0.9926 High Similarity NPC316911
0.9706 High Similarity NPC54820
0.9706 High Similarity NPC268178
0.9706 High Similarity NPC180501
0.9343 High Similarity NPC101752
0.9291 High Similarity NPC325346
0.9281 High Similarity NPC272844
0.9281 High Similarity NPC248995
0.9281 High Similarity NPC254168
0.9214 High Similarity NPC240305
0.9149 High Similarity NPC221173
0.9149 High Similarity NPC471587
0.9143 High Similarity NPC477056
0.9143 High Similarity NPC470669
0.9143 High Similarity NPC477055
0.9143 High Similarity NPC470668
0.9116 High Similarity NPC470353
0.9091 High Similarity NPC11700
0.9085 High Similarity NPC205006
0.9085 High Similarity NPC470555
0.9085 High Similarity NPC156590
0.9085 High Similarity NPC118840
0.9085 High Similarity NPC64908
0.9085 High Similarity NPC147688
0.9078 High Similarity NPC220062
0.9078 High Similarity NPC270913
0.9078 High Similarity NPC53181
0.9078 High Similarity NPC301217
0.9078 High Similarity NPC23257
0.9078 High Similarity NPC303633
0.9078 High Similarity NPC217186
0.9078 High Similarity NPC55018
0.9078 High Similarity NPC96565
0.9078 High Similarity NPC216978
0.9078 High Similarity NPC472343
0.906 High Similarity NPC470352
0.906 High Similarity NPC470354
0.9028 High Similarity NPC278175
0.9028 High Similarity NPC71184
0.9028 High Similarity NPC257236
0.9028 High Similarity NPC472447
0.9028 High Similarity NPC206212
0.9028 High Similarity NPC472446
0.9021 High Similarity NPC226636
0.9021 High Similarity NPC78803
0.9021 High Similarity NPC217083
0.9021 High Similarity NPC62840
0.9021 High Similarity NPC214236
0.9021 High Similarity NPC59739
0.9021 High Similarity NPC293852
0.9021 High Similarity NPC299080
0.9021 High Similarity NPC11561
0.9014 High Similarity NPC241100
0.9014 High Similarity NPC150522
0.9014 High Similarity NPC475680
0.9014 High Similarity NPC289660
0.9014 High Similarity NPC164697
0.9014 High Similarity NPC270883
0.9014 High Similarity NPC261227
0.9014 High Similarity NPC82920
0.9014 High Similarity NPC235239
0.9014 High Similarity NPC172986
0.9014 High Similarity NPC159275
0.9014 High Similarity NPC305355
0.9007 High Similarity NPC131130
0.9007 High Similarity NPC470083
0.9007 High Similarity NPC219584
0.9007 High Similarity NPC201395
0.9 High Similarity NPC174999
0.898 High Similarity NPC188403
0.8966 High Similarity NPC329678
0.8958 High Similarity NPC38219
0.8958 High Similarity NPC473813
0.8958 High Similarity NPC473812
0.8958 High Similarity NPC219915
0.8951 High Similarity NPC103362
0.8951 High Similarity NPC110969
0.8951 High Similarity NPC111201
0.8951 High Similarity NPC282300
0.8944 High Similarity NPC78913
0.8944 High Similarity NPC241975
0.8944 High Similarity NPC19476
0.8944 High Similarity NPC18260
0.8936 High Similarity NPC474624
0.8936 High Similarity NPC138047
0.8936 High Similarity NPC131782
0.8929 High Similarity NPC151113
0.8921 High Similarity NPC108113
0.8921 High Similarity NPC93756
0.8921 High Similarity NPC16197
0.8919 High Similarity NPC81474
0.8904 High Similarity NPC283234
0.8897 High Similarity NPC234629
0.8897 High Similarity NPC311741
0.8897 High Similarity NPC469953
0.8897 High Similarity NPC469935
0.8897 High Similarity NPC178627
0.8889 High Similarity NPC36181
0.8889 High Similarity NPC144499
0.8889 High Similarity NPC200694
0.8889 High Similarity NPC204469
0.8881 High Similarity NPC477272
0.8881 High Similarity NPC69769
0.8873 High Similarity NPC199458
0.8873 High Similarity NPC474487
0.8873 High Similarity NPC470671
0.8873 High Similarity NPC474504
0.8873 High Similarity NPC470672
0.8873 High Similarity NPC183639
0.8865 High Similarity NPC470982
0.8865 High Similarity NPC470983
0.8865 High Similarity NPC13408
0.8857 High Similarity NPC125920
0.8849 High Similarity NPC10971
0.8849 High Similarity NPC15834
0.8849 High Similarity NPC215875
0.8844 High Similarity NPC469933
0.8844 High Similarity NPC132592
0.8844 High Similarity NPC160821
0.8836 High Similarity NPC127059
0.8836 High Similarity NPC181388
0.8836 High Similarity NPC20488
0.8836 High Similarity NPC312973
0.8836 High Similarity NPC67805
0.8836 High Similarity NPC142405
0.8836 High Similarity NPC176229
0.8836 High Similarity NPC88964
0.8836 High Similarity NPC301276
0.8836 High Similarity NPC285630
0.8836 High Similarity NPC111786
0.8836 High Similarity NPC246948
0.8836 High Similarity NPC83357
0.8836 High Similarity NPC82534
0.8836 High Similarity NPC54577
0.8836 High Similarity NPC220418
0.8836 High Similarity NPC195621
0.8836 High Similarity NPC470647
0.8836 High Similarity NPC124729
0.8836 High Similarity NPC267375
0.8836 High Similarity NPC475052
0.8836 High Similarity NPC214774
0.8836 High Similarity NPC57470
0.8828 High Similarity NPC188632
0.8828 High Similarity NPC106985
0.8828 High Similarity NPC190637
0.8828 High Similarity NPC196459
0.8828 High Similarity NPC316816
0.8828 High Similarity NPC470296
0.8828 High Similarity NPC18585
0.8828 High Similarity NPC24821
0.8828 High Similarity NPC293053
0.8828 High Similarity NPC112791
0.8828 High Similarity NPC5990
0.8828 High Similarity NPC212932
0.8828 High Similarity NPC166138
0.8828 High Similarity NPC94794
0.8828 High Similarity NPC87609
0.8828 High Similarity NPC214166
0.8828 High Similarity NPC9117
0.8828 High Similarity NPC478086
0.8828 High Similarity NPC185276
0.8824 High Similarity NPC316625
0.8824 High Similarity NPC329205
0.8819 High Similarity NPC248372
0.8819 High Similarity NPC110038
0.8819 High Similarity NPC14871
0.8811 High Similarity NPC139554
0.8811 High Similarity NPC473076
0.8803 High Similarity NPC255801
0.8803 High Similarity NPC322301
0.8794 High Similarity NPC60667
0.8794 High Similarity NPC46869
0.8792 High Similarity NPC476162
0.8784 High Similarity NPC469932
0.8776 High Similarity NPC24673
0.8776 High Similarity NPC249942
0.8776 High Similarity NPC201731
0.8776 High Similarity NPC166757
0.8776 High Similarity NPC110303
0.8776 High Similarity NPC10990
0.8776 High Similarity NPC297886
0.8776 High Similarity NPC285748
0.8776 High Similarity NPC97716
0.8776 High Similarity NPC237635
0.8776 High Similarity NPC473077
0.8776 High Similarity NPC14001
0.8776 High Similarity NPC296998
0.8776 High Similarity NPC300988
0.8776 High Similarity NPC180477
0.8776 High Similarity NPC140120
0.8776 High Similarity NPC104406
0.8776 High Similarity NPC23728
0.8776 High Similarity NPC79469
0.8767 High Similarity NPC235217
0.8767 High Similarity NPC470673
0.8767 High Similarity NPC131579

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC326193 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9058 High Similarity NPD6651 Approved
0.9028 High Similarity NPD7410 Clinical (unspecified phase)
0.8944 High Similarity NPD2800 Approved
0.8767 High Similarity NPD4378 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8414 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8414 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8356 Intermediate Similarity NPD1549 Phase 2
0.8312 Intermediate Similarity NPD7819 Suspended
0.8301 Intermediate Similarity NPD7411 Suspended
0.8276 Intermediate Similarity NPD1510 Phase 2
0.8269 Intermediate Similarity NPD7075 Discontinued
0.8252 Intermediate Similarity NPD1240 Approved
0.8235 Intermediate Similarity NPD4380 Phase 2
0.8219 Intermediate Similarity NPD2796 Approved
0.8194 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8138 Intermediate Similarity NPD1607 Approved
0.8129 Intermediate Similarity NPD6801 Discontinued
0.8079 Intermediate Similarity NPD1511 Approved
0.8077 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8037 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3750 Approved
0.7975 Intermediate Similarity NPD7768 Phase 2
0.7974 Intermediate Similarity NPD1512 Approved
0.7963 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD2801 Approved
0.7925 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD2532 Approved
0.7908 Intermediate Similarity NPD2534 Approved
0.7908 Intermediate Similarity NPD2533 Approved
0.7898 Intermediate Similarity NPD1934 Approved
0.7885 Intermediate Similarity NPD6599 Discontinued
0.7881 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7867 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7852 Intermediate Similarity NPD6099 Approved
0.7852 Intermediate Similarity NPD6100 Approved
0.7843 Intermediate Similarity NPD6799 Approved
0.7815 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD1243 Approved
0.7778 Intermediate Similarity NPD6959 Discontinued
0.774 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD5124 Phase 1
0.7702 Intermediate Similarity NPD3749 Approved
0.7688 Intermediate Similarity NPD3817 Phase 2
0.7667 Intermediate Similarity NPD3748 Approved
0.764 Intermediate Similarity NPD3882 Suspended
0.7636 Intermediate Similarity NPD6166 Phase 2
0.7636 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD2313 Discontinued
0.7605 Intermediate Similarity NPD7054 Approved
0.759 Intermediate Similarity NPD7473 Discontinued
0.758 Intermediate Similarity NPD920 Approved
0.758 Intermediate Similarity NPD5403 Approved
0.7566 Intermediate Similarity NPD2344 Approved
0.756 Intermediate Similarity NPD7472 Approved
0.756 Intermediate Similarity NPD7074 Phase 3
0.755 Intermediate Similarity NPD2799 Discontinued
0.7548 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD3818 Discontinued
0.7532 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD7808 Phase 3
0.7529 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD5953 Discontinued
0.7515 Intermediate Similarity NPD6232 Discontinued
0.75 Intermediate Similarity NPD1551 Phase 2
0.75 Intermediate Similarity NPD7286 Phase 2
0.75 Intermediate Similarity NPD2935 Discontinued
0.7483 Intermediate Similarity NPD422 Phase 1
0.7471 Intermediate Similarity NPD7251 Discontinued
0.7452 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD5401 Approved
0.7431 Intermediate Similarity NPD9717 Approved
0.7412 Intermediate Similarity NPD6797 Phase 2
0.7397 Intermediate Similarity NPD1203 Approved
0.7394 Intermediate Similarity NPD5494 Approved
0.7383 Intermediate Similarity NPD3268 Approved
0.7375 Intermediate Similarity NPD3226 Approved
0.7372 Intermediate Similarity NPD2309 Approved
0.7368 Intermediate Similarity NPD6559 Discontinued
0.7365 Intermediate Similarity NPD6832 Phase 2
0.732 Intermediate Similarity NPD7033 Discontinued
0.732 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD4628 Phase 3
0.7305 Intermediate Similarity NPD5710 Approved
0.7305 Intermediate Similarity NPD5711 Approved
0.7279 Intermediate Similarity NPD2797 Approved
0.7278 Intermediate Similarity NPD7390 Discontinued
0.7267 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD5402 Approved
0.7244 Intermediate Similarity NPD2654 Approved
0.723 Intermediate Similarity NPD2798 Approved
0.7229 Intermediate Similarity NPD919 Approved
0.7226 Intermediate Similarity NPD2346 Discontinued
0.7225 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD4308 Phase 3
0.7203 Intermediate Similarity NPD1548 Phase 1
0.7192 Intermediate Similarity NPD3972 Approved
0.7171 Intermediate Similarity NPD943 Approved
0.7168 Intermediate Similarity NPD6104 Discontinued
0.716 Intermediate Similarity NPD3926 Phase 2
0.7153 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1296 Phase 2
0.7143 Intermediate Similarity NPD1247 Approved
0.7143 Intermediate Similarity NPD4749 Approved
0.7133 Intermediate Similarity NPD4908 Phase 1
0.7123 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD4360 Phase 2
0.7111 Intermediate Similarity NPD4363 Phase 3
0.7095 Intermediate Similarity NPD3225 Approved
0.7093 Intermediate Similarity NPD5844 Phase 1
0.7086 Intermediate Similarity NPD4625 Phase 3
0.7073 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD4361 Phase 2
0.7072 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD8434 Phase 2
0.7055 Intermediate Similarity NPD7458 Discontinued
0.7052 Intermediate Similarity NPD1729 Discontinued
0.7048 Intermediate Similarity NPD4288 Approved
0.7047 Intermediate Similarity NPD3267 Approved
0.7047 Intermediate Similarity NPD3266 Approved
0.7012 Intermediate Similarity NPD6585 Discontinued
0.7011 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD1610 Phase 2
0.7 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.6988 Remote Similarity NPD1465 Phase 2
0.698 Remote Similarity NPD8651 Approved
0.6972 Remote Similarity NPD1241 Discontinued
0.6968 Remote Similarity NPD7584 Approved
0.6966 Remote Similarity NPD9545 Approved
0.6948 Remote Similarity NPD4307 Phase 2
0.6944 Remote Similarity NPD9493 Approved
0.6933 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6928 Remote Similarity NPD411 Approved
0.6919 Remote Similarity NPD2403 Approved
0.6919 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6919 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6914 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6903 Remote Similarity NPD447 Suspended
0.6889 Remote Similarity NPD4287 Approved
0.6886 Remote Similarity NPD5761 Phase 2
0.6886 Remote Similarity NPD5760 Phase 2
0.6875 Remote Similarity NPD7003 Approved
0.6871 Remote Similarity NPD5049 Phase 3
0.6867 Remote Similarity NPD5889 Approved
0.6867 Remote Similarity NPD5890 Approved
0.6846 Remote Similarity NPD1608 Approved
0.6845 Remote Similarity NPD2296 Approved
0.6839 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6835 Remote Similarity NPD5404 Approved
0.6835 Remote Similarity NPD5405 Approved
0.6835 Remote Similarity NPD5406 Approved
0.6835 Remote Similarity NPD5408 Approved
0.6818 Remote Similarity NPD3764 Approved
0.6802 Remote Similarity NPD7229 Phase 3
0.6798 Remote Similarity NPD8313 Approved
0.6798 Remote Similarity NPD8312 Approved
0.6797 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6797 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6796 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6795 Remote Similarity NPD230 Phase 1
0.6795 Remote Similarity NPD1933 Approved
0.6792 Remote Similarity NPD1471 Phase 3
0.6779 Remote Similarity NPD1201 Approved
0.6776 Remote Similarity NPD1019 Discontinued
0.6776 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6772 Remote Similarity NPD651 Clinical (unspecified phase)
0.675 Remote Similarity NPD2424 Discontinued
0.6743 Remote Similarity NPD5940 Clinical (unspecified phase)
0.6732 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6728 Remote Similarity NPD2354 Approved
0.6725 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6711 Remote Similarity NPD1164 Approved
0.6711 Remote Similarity NPD1470 Approved
0.671 Remote Similarity NPD6798 Discontinued
0.6708 Remote Similarity NPD1652 Phase 2
0.6688 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6687 Remote Similarity NPD6002 Phase 3
0.6687 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6687 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6687 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6687 Remote Similarity NPD6005 Phase 3
0.6687 Remote Similarity NPD6004 Phase 3
0.6686 Remote Similarity NPD8455 Phase 2
0.6686 Remote Similarity NPD3446 Phase 1
0.6685 Remote Similarity NPD8150 Discontinued
0.6667 Remote Similarity NPD8032 Phase 2
0.6648 Remote Similarity NPD3751 Discontinued
0.6647 Remote Similarity NPD7199 Phase 2
0.6647 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6646 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6645 Remote Similarity NPD6696 Suspended
0.6645 Remote Similarity NPD7095 Approved
0.6644 Remote Similarity NPD1778 Approved
0.6644 Remote Similarity NPD17 Approved
0.6644 Remote Similarity NPD6671 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data